<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Floyd Bach | Activity</title>
	<link>https://brycefoster.com/members/piscesthing9/activity/</link>
	<atom:link href="https://brycefoster.com/members/piscesthing9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Floyd Bach.</description>
	<lastBuildDate>Sun, 21 Jun 2026 14:38:24 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7b63ac97db822484e375ec0cf4b6bfa9</guid>
				<title>Floyd Bach posted an update: Ozempic Availability in the UK: A Comprehensive [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1343759/</link>
				<pubDate>Wed, 04 Mar 2026 11:55:11 +0000</pubDate>

									<content:encoded><![CDATA[<p>Ozempic Availability in the UK: A Comprehensive Guide</p>
<p>Introduction</p>
<p>Ozempic (semaglutide) has become an important medication for managing type 2 diabetes and has actually also gotten attention for its weight-loss advantages. Originally developed by Novo Nordisk, this injectable medication simulates the results of the GLP-1 hormone, promoting&hellip;<span class="activity-read-more" id="activity-read-more-1343759"><a href="https://brycefoster.com/activity/p/1343759/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fadf8da39d125be66f88a24e593096ec</guid>
				<title>Floyd Bach became a registered member</title>
				<link>https://brycefoster.com/activity/p/1343756/</link>
				<pubDate>Wed, 04 Mar 2026 11:54:50 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>